lobbying_activities: 2300519

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2300519	c03c96a0-1668-4cb1-aa8b-4f80a3611854	Q2	THORN RUN PARTNERS	400534596	BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.	2019	second_quarter	MMM	Issues related to Medicare and Medicaid reimbursement for pharmaceuticals. Medicare reimbursement for biosimilars.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2019-07-09T16:41:19.533000-04:00